CAS RN: 1385821-29-3
1H-Indazole,5-broMo-4-trifluoroMethyl
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1385821-29-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Beijing
Inquiry
1385821-29-3 / 5-bromo-4-(trifluoromethyl)-1H-indazole
Standard CAS: 1385821-29-3
Multi CAS: No
Basic Information
copy
CAS
1385821-29-3 copy
Multi CAS
No copy
Molecular Formula
C8H4BrF3N2 copy
Molecular Weight
265.030000 copy
Exact Mass
263.951000 copy
SMILES
C1=CC(=C(C2=C1NN=C2)C(F)(F)F)Br copy
InChI
InChI=1S/C8H4BrF3N2/c9-5-1-2-6-4(3-13-14-6)7(5)8(10,11)12/h1-3H,(H,13,14) copy
InChIKey
FECZIZNDPJXBMQ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.12 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
48.8 copy
TPSA
28.68 copy
LogP / Solubility
WLOGP
3.34 copy
MLOGP
2.95 copy
XLogP3
3.1 copy
Consensus LogP
3.13 copy
Log S (ESOL)
-4.07 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-4.15 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.16 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.96 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy